View in EDS HTML Full Text PDF Full Text

Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer.
Authors: Bedoya-López AF; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain., Ahn S; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Kangnam Sacred Heart Hospital, Hallym University, Seoul, South Korea., Ensenyat-Mendez M; Department of Surgery, Duke University School of Medicine, Durham, NC, USA., Orozco JIJ; Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Iñiguez-Muñoz S; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain., Llinàs-Arias P; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain., Thomas SM; Department of Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, NC, USA.; Duke Cancer Institute, Duke University, Durham, NC, USA., Baker JL; Department of Surgery, University of California Los Angeles, Los Angeles, USA., Sullivan PS; Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, USA., Makker J; Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, USA., Steele JB; Department of Pathology and Laboratory Medicine, Scripps Clinic Medical Group, San Diego, CA, USA., Kurian SM; Scripps Clinic Biorepository and Bioinformatics, San Diego, CA, USA., Marzese DM; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain. diego.marzese@idisba.es.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA. diego.marzese@idisba.es.; Duke Cancer Institute, Duke University, Durham, NC, USA. diego.marzese@idisba.es., DiNome ML; Department of Surgery, Duke University School of Medicine, Durham, NC, USA. Maggie.DiNome@Duke.edu.; Duke Cancer Institute, Duke University, Durham, NC, USA. Maggie.DiNome@Duke.edu.
Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Mar 30; Vol. 10 (1). Date of Electronic Publication: 2026 Mar 30.
Publication Type: Published Erratum
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41912730
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bedoya-López+AF%22">Bedoya-López AF</searchLink>; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.<br /><searchLink fieldCode="AU" term="%22Ahn+S%22">Ahn S</searchLink>; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.; Department of Surgery, Kangnam Sacred Heart Hospital, Hallym University, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Ensenyat-Mendez+M%22">Ensenyat-Mendez M</searchLink>; Department of Surgery, Duke University School of Medicine, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Orozco+JIJ%22">Orozco JIJ</searchLink>; Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Iñiguez-Muñoz+S%22">Iñiguez-Muñoz S</searchLink>; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.<br /><searchLink fieldCode="AU" term="%22Llinàs-Arias+P%22">Llinàs-Arias P</searchLink>; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.<br /><searchLink fieldCode="AU" term="%22Thomas+SM%22">Thomas SM</searchLink>; Department of Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, NC, USA.; Duke Cancer Institute, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Baker+JL%22">Baker JL</searchLink>; Department of Surgery, University of California Los Angeles, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Sullivan+PS%22">Sullivan PS</searchLink>; Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Makker+J%22">Makker J</searchLink>; Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Steele+JB%22">Steele JB</searchLink>; Department of Pathology and Laboratory Medicine, Scripps Clinic Medical Group, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kurian+SM%22">Kurian SM</searchLink>; Scripps Clinic Biorepository and Bioinformatics, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Marzese+DM%22">Marzese DM</searchLink>; Cancer Epigenetics Laboratory, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain. diego.marzese@idisba.es.; Department of Surgery, Duke University School of Medicine, Durham, NC, USA. diego.marzese@idisba.es.; Duke Cancer Institute, Duke University, Durham, NC, USA. diego.marzese@idisba.es.<br /><searchLink fieldCode="AU" term="%22DiNome+ML%22">DiNome ML</searchLink>; Department of Surgery, Duke University School of Medicine, Durham, NC, USA. Maggie.DiNome@Duke.edu.; Duke Cancer Institute, Duke University, Durham, NC, USA. Maggie.DiNome@Duke.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2026 Mar 30; Vol. 10 (1). <i>Date of Electronic Publication: </i>2026 Mar 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41912730
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41698-026-01367-4
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bedoya-López AF
      – PersonEntity:
          Name:
            NameFull: Ahn S
      – PersonEntity:
          Name:
            NameFull: Ensenyat-Mendez M
      – PersonEntity:
          Name:
            NameFull: Orozco JIJ
      – PersonEntity:
          Name:
            NameFull: Iñiguez-Muñoz S
      – PersonEntity:
          Name:
            NameFull: Llinàs-Arias P
      – PersonEntity:
          Name:
            NameFull: Thomas SM
      – PersonEntity:
          Name:
            NameFull: Baker JL
      – PersonEntity:
          Name:
            NameFull: Sullivan PS
      – PersonEntity:
          Name:
            NameFull: Makker J
      – PersonEntity:
          Name:
            NameFull: Steele JB
      – PersonEntity:
          Name:
            NameFull: Kurian SM
      – PersonEntity:
          Name:
            NameFull: Marzese DM
      – PersonEntity:
          Name:
            NameFull: DiNome ML
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 03
              Text: 2026 Mar 30
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2397-768X
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ precision oncology
              Type: main
ResultId 1